title: [Adenosine triphosphate (ATP) in the management of paroxysmal supraventricular tachycardia: experience in the neonatal period].
abstract: OBJECTIVE
  The management of supraventricular tachycardia (SVT) in infants is somewhat controversial since numerous methods of treatment are effective. Regardless of the treatment chosen, it is important to quickly stop the tachycardia in neonates with SVT because they may suddenly become hemodynamically unstable.
  
  
  METHODS
  Seventeen episodes of SVT treated with intravenous ATP are studied in 3 newborns (two were preterm infants: 30 and 34 weeks of pregnancy). Ages at presentation ranged from 2 to 27 days.
  
  
  RESULTS
  ATP is effective in all episodes of SVT, with a mean intravenous doses between 0.10 and 0.50 mg/kg/dose. All patients showed short sinus arrest after ATP. No adverse side effects or hemodynamics changes occurred after ATP administration.
  
  
  CONCLUSIONS
  ATP is a safe and reliable antiarrhythmic in neonatal period, including prematurity. We reviewed the experience in ATP management of SVT, mainly in pediatric population.
authors.affiliation: Servicio de Cardiología, Hospital Infantil La Paz, Madrid.
authors.forename: J
authors.initials: J
authors.lastname: González de Dios
authors.forename: M
authors.initials: M
authors.lastname: Burgueros Valero
authors.forename: L
authors.initials: L
authors.lastname: García Guereta
authors.forename: F
authors.initials: F
authors.lastname: Moreno Granados
authors.forename: J
authors.initials: J
authors.lastname: Pérez Rodríguez
authors.forename: J
authors.initials: J
authors.lastname: Quero Jiménez
mesh_terms: D000241:Adenosine / Q000008:administration & dosage / Q000627:therapeutic use; D000255:Adenosine Triphosphate / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000367:Age Factors; D002648:Child; D004070:Digitalis; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy; D007275:Injections, Intravenous; D008297:Male; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011802:Quinidine / Q000627:therapeutic use; D012016:Reference Values; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy*; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*
chemical_list: D000255:Adenosine Triphosphate; D011802:Quinidine; D000241:Adenosine
vernacular_title: Manejo del adenosín trifosfato (ATP) en la taquicardia paroxística supraventricular: experiencia en el período neonatal.